发明名称 |
5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-1,2-DIHYDROQUINOLINE-3-CARBOXAMIDE, SALTS THEREOF AND USES THEREOF |
摘要 |
PROBLEM TO BE SOLVED: To provide laquinimod preparations and methods of producing the same that minimize the amount of DELAQ (des-ethyl-laquinimod; 5-chloro-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide), which is an undesirable synthetic by-product of laquinimod synthesis used in treatment of multiple sclerosis (MS).SOLUTION: A production method comprises: determining by an apparatus the total amount of DELAQ in a sample of a laquinimod batch; and validating the batch for distribution if the sample of the batch is determined to contain DELAQ of less than 0.1 wt.% relative to the combined weight of laquinimod and DELAQ. Also provided is a pharmaceutical composition using the batch.SELECTED DRAWING: None |
申请公布号 |
JP2016053049(A) |
申请公布日期 |
2016.04.14 |
申请号 |
JP20150204932 |
申请日期 |
2015.10.16 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
发明人 |
ULF TOMAS FRISTEDT |
分类号 |
A61K31/4704;C07D215/54 |
主分类号 |
A61K31/4704 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|